Angold, A, Costello, EJ and Messer, SC (1995) Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. International Journal of Methods in Psychiatric Research 5, 237–249.
Barnett, JH et al. (2006) Cognitive reserve in neuropsychiatry. Psychological Medicine 36, 1053–1064.
Boyd, A et al. (2013) Cohort profile: the ‘children of the 90s’ – the index offspring of the Avon Longitudinal Study of Parents and Children. International Journal of Epidemiology 42, 111–127.
Cannon, M et al. (2002) Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Archives of General Psychiatry 59, 449–456.
Cannon, TD et al. (2000) Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophrenia Bulletin 26, 379–393.
Collins, LM and Lanza, ST (2010) Latent Class and Latent Transition Analysis: With Applications in the Social, Behavioral, and Health Sciences, pp. 287–295. John Wiley & Sons, Inc.
Colman, I et al. (2007) A longitudinal typology of symptoms of depression and anxiety over the life course. Biological Psychiatry 62, 1265–1271.
Costello, EJ et al. (1982) The National Institute of Mental Health Diagnostic Interview Schedule for Children (DISC). NIMH, Bethesda, MD, USA.
Danesh, J et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine 350, 1387–1397.
Dantzer, R et al. (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 9, 46–56.
David, AS et al. (1997) IQ and risk for schizophrenia: a population-based cohort study. Psychological Medicine 27, 1311–1323.
Davidson, M et al. (1999) Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. American Journal of Psychiatry 156, 1328–1335.
de Jager, W et al. (2009) Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunology 10, 52.
Finch, AJ and Chihldress, WB (1975) A comparison of WISC selected subtest short forms with MR children. Mental Retardation 13, 20–21.
Galler, JR, Koethe, JR and Yolken, RH (2017) Neurodevelopment: the impact of nutrition and inflammation during adolescence in low-resource settings. Pediatrics Supplement 139, s72–s84.
Gimeno, D et al. (2009) Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychological Medicine 39, 413–423.
Gogtay, N et al. (2004) Dynamic mapping of human cortical development during childhood through early adulthood. Proceedings of the National Academy of Sciences of the United States of America 101, 8174–8179.
Goldsmith, DR, Rapaport, MH and Miller, BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Molecular Psychiatry 21, 1696–1709.
Goodman, R (1997) The strengths and difficulties questionnaire: a research note. Journal of Child Psychology and Psychiatry 38, 581–586.
Haapakoski, R et al. (2015) Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain Behaviour and Immunity 49, 206–215.
Harrison, NA et al. (2009) Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biological Psychiatry 66, 407–414.
Hayes, JF et al. (2016) Childhood interleukin-6, C-reactive protein and atopic disorders as risk factors for hypomanic symptoms in young adulthood: a longitudinal birth cohort study. Psychological Medicine 47, 23–33.
Horwood, J et al. (2008) IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. British Journal of Psychiatry 193, 185–191.
Howren, MB, Lamkin, DM and Suls, J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71, 171–186.
Iwashyna, TJ et al. (2010) Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304, 1787–1794.
John, CC, Black, MM and Nelson, CA III (2017) Neurodevelopment: the impact of nutrition and inflammation during early to middle childhood in low-resource settings. Pediatrics Supplement 139, s59–s71.
Jones, P et al. (1994) Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344, 1398–1402.
Jones, PB (2013) Adult mental health disorders and their age at onset. British Journal of Psychiatry Supplement 54, s5–s10.
Kessler, RC et al. (2003) The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA 289, 3095–3105.
Kessler, RC et al. (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 62, 593–602.
Khandaker, GM et al. (2011) A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophrenia Research 132, 220–227.
Khandaker, GM et al. (2015) Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. The Lancet Psychiatry 2, 258–270.
Khandaker, GM et al. (2014 a). Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 71, 1121–1128.
Khandaker, GM et al. (2014 b). A population-based longitudinal study of childhood neurodevelopmental disorders, IQ and subsequent risk of psychotic experiences in adolescence. Psychological Medicine 44, 3229–3238.
Khandaker, GM et al. (2014 c). A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence. Schizophrenia Research 152, 139–145.
Khandaker, GM et al. (2016) Association between serum C-reactive protein and DSM-IV generalized anxiety disorder in adolescence: findings from the ALSPAC cohort. Neurobiology of Stress 4, 55–61.
Khandaker, GM et al. (2013) Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychological Medicine 43, 239–257.
Knudsen, LS et al. (2008) Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis. Biomarkers 13, 59–78.
Koenen, KC et al. (2007) Early childhood factors associated with the development of post-traumatic stress disorder: results from a longitudinal birth cohort. Psychological Medicine 37, 181–192.
Koenen, KC et al. (2009) Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. American Journal of Psychiatry 166, 50–57.
Kremen, WS et al. (2007) Pretrauma cognitive ability and risk for posttraumatic stress disorder: a twin study. Archives of General Psychiatry 64, 361–368.
Merikangas, KR et al. (2003) Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich cohort study. Archives of General Psychiatry 60, 993–1000.
Metcalf, SA et al. (2017) Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: a prospective birth cohort study. Brain Behaviour and Immunity 59, 253–259.
Mortensen, EL et al. (2005) IQ and mental disorder in young men. British Journal of Psychiatry 187, 407–415.
Owens, M et al. (2014) Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms. Proceedings of the National Academy of Sciences of the United States of America 111, 3638–3643.
Raison, CL, Capuron, L and Miller, AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 27, 24–31.
Reichenberg, A et al. (2001) Cytokine-associated emotional and cognitive disturbances in humans. Archives of General Psychiatry 58, 445–452.
Rutter, M, Kim-Cohen, J and Maughan, B (2006) Continuities and discontinuities in psychopathology between childhood and adult life. Journal of Child Psychology and Psychiatry 47, 276–295.
Schwarz, GE (1978) Estimating the dimension of a model. Annals of Statistics 6, 461–464.
Sekar, A et al. (2016) Schizophrenia risk from complex variation of complement component 4. Nature 530, 177–183.
Sharp, C, Goodyer, IM and Croudace, TJ (2006) The short mood and feelings questionnaire (SMFQ): a unidimensional item response theory and categorical data factor analysis of self-report ratings from a community sample of 7-through 11-year-old children. Journal of Abnormal Child Psychology 34, 379–391.
Stricker, G, Merbaum, M and Tangeman, P (1968) WAIS short forms, information transmission and approximation of full scale IQ. Journal of Clinical Psychology 25, 170–172.
Thapar, A and McGuffin, P (1998) Validity of the shortened mood and feelings questionnaire in a community sample of children and adolescents: a preliminary research note. Psychiatry Research 81, 259–268.
van Os, J et al. (1997) Developmental precursors of affective illness in a general population birth cohort. Archives of General Psychiatry 54, 625–631.
Wechsler, D, Golombok, S and Rust, J (1992) Weschler Intelligence Scale for Children, 3rd edn. (WISC–III UK). The Psychological Corporation, Sidcup.
Whalley, LJ and Deary, IJ (2001) Longitudinal cohort study of childhood IQ and survival up to age 76. BMJ 322, 819.
Wium-Andersen, MK, Orsted, DD and Nordestgaard, BG (2014) Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study. Schizophrenia Bulletin 40, 1117–1127.
Woodberry, KA, Giuliano, AJ and Seidman, LJ (2008) Premorbid IQ in schizophrenia: a meta-analytic review. American Journal of Psychiatry 165, 579–587.
Zalli, A et al. (2016) Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology (Berlin) 233, 1669–1678.
Zammit, S et al. (2004) A longitudinal study of premorbid IQ score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Archives of General Psychiatry 61, 354–360.